Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Biofrontera Inc. Common Stock
BFRI | US
0.86
USD-0.03
-3.72%
BFRI | US
About Biofrontera Inc. Common Stock
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
05/03/2026
Close
0.86
Open
0.88
High
0.90
Low
0.85
Biofrontera Inc. a biopharmaceutical company engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz a prescription drug; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi a prescription drug for the treatment of impetigo. The company was founded in 1997 and is headquartered in Woburn Massachusetts.
View LessBFRI | US
Risk
72.9
Sharpe
-0.03
Luna's Score
54/100
Recommendation
Hold
Luna says (BFRI | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
63.6%1 month
72.9%3 months
98.4%6 months
84.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.43
Debt to equity
0.13
Debt to assets
0.07
Ent. to EBITDA
-0.79
Ent. to rev.
0.05
PEG
-
Other Fundamentals
EBITDA
-18.32M
MarketCap
4.78M
MarketCap(USD)
4.78M
Div. yield
-
Op. margin
-64.69
Erngs. growth
-
Rev. growth
34.00
Ret. on equity
-149.41
Short ratio
0.43
Short perc.
3.63
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.15
Range1M
0.31
Range3M
0.46
Volumes: Market Activity
Rel. volume
0.03
Price X volume
21.81K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.79 | 24.85 | Cheaper |
| Ent. to Revenue | 0.05 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.43 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 98.42 | 65.24 | Riskier |
| Debt to Equity | 0.13 | -1.88 | Expensive |
| Debt to Assets | 0.07 | 0.48 | Cheaper |
| Market Cap | 4.78M | 3.71B | Emerging |
